An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (0431-024)

• Status: Completed
• Trial end date: 2007-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this investigational study is to determine the safety and effectiveness of an investigational drug in patients with type 2 diabetes mellitus (a specific type of diabetes).

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Glipizide; Sitagliptin Phosphate

Criteria

Inclusion Criteria:

• Patients who are at least 18 years of age and not older than 78 with type 2 diabetes mellitus